|
1
|
Thompson CB: Apoptosis in the pathogenesis
and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar
|
|
2
|
Barinaga M: Death by dozens of cuts.
Science. 280:32–34. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kiechle FL and Zhang X: Apoptosis:
biochemical aspects and clinical implications. Clin Chim Acta.
326:27–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crook NE, Clem RJ and Miller LK: An
apoptosis-inhibiting baculovirus gene with a zinc finger-like
motif. J Virol. 67:2168–2174. 1993.PubMed/NCBI
|
|
5
|
LaCasse EC, Baird S, Korneluk RG and
MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging
role in cancer. Oncogene. 17:3247–3259. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adamkov M, Výbohová D, Horáček J, Kovalská
M and Furjelová M: Survivin expression in breast lobular carcinoma:
correlations with normal breast tissue and clinicomorphological
parameters. Acta Histochem. 115:412–417. 2013. View Article : Google Scholar
|
|
7
|
Li F, Yang J, Ramnath N, Javle MM and Tan
D: Nuclear or cytoplasmic expression of survivin: what is the
significance? Int J Cancer. 114:509–512. 2005. View Article : Google Scholar
|
|
8
|
Li F and Brattain MG: Role of the survivin
gene in pathophysiology. Am J Pathol. 169:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee WS, Cho SB, Rew JS, Lee JH, Park CS
and Joo YE: Expression of survivin in gastric carcinoma and its
relation to tumor cell proliferation and apoptosis. Kor J Pathol.
43:329–334. 2009. View Article : Google Scholar
|
|
10
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptotic gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Altieri DC: Survivin, cancer networks and
pathway-directed drug discovery. Nat Rev Cancer. 81:61–70. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mita AC, Mita MM, Nawrocki ST and Giles
FJ: Survivin: key regulator of mitosis and apoptosis and novel
target for cancer therapeutics. Clin Cancer Res. 14:5000–5005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
14
|
Adams JM and Cory S: Life-or-death
decisions by the Bcl-2 protein family. Trends Biochem Sci.
26:61–66. 2001. View Article : Google Scholar
|
|
15
|
Qi G, Tuncel H, Aoki E, Tanaka S, Oka S,
Kaneko I, et al: Intracellular localization of survivin determines
biological behavior in colorectal cancer. Oncol Rep. 22:557–562.
2009.PubMed/NCBI
|
|
16
|
Tanaka K, Iwamoto S, Gon G, Nohara T,
Iwamoto M and Tanigawa N: Expression of survivin and its
relationship to loss of apoptosis in breast carcinomas. Clin Cancer
Res. 6:127–134. 2000.PubMed/NCBI
|
|
17
|
Adida C, Haioun C, Gaulard P, Lepage E,
Morel P, Briere J, et al: Prognostic significance of survivin
expression in diffuse large B-cell lymphomas. Blood. 96:1921–1925.
2000.PubMed/NCBI
|
|
18
|
Monzó M, Rosell R, Felip E, Astudillo J,
Sánchez JJ, Maestre J, et al: A novel anti-apoptosis gene:
Re-expression of survivin messenger RNA as a prognosis marker in
non-small-cell lung cancers. J Clin Onol. 17:2100–2104.
1999.PubMed/NCBI
|
|
19
|
Ikeguchi M, Ueta T, Yamane Y, Hirooka Y
and Kaibara N: Inducible nitric oxide synthase and survivin
messenger RNA expression in hepatocellular carcinoma. Clin Cancer
Res. 8:3131–3136. 2002.
|
|
20
|
Wakana Y, Kasuya K, Katayanagi S, Tsuchida
A, Aoki T, Koyanagi Y, et al: Effect of survivin on cell
proliferation and apoptosis in gastric cancer. Oncol Rep.
9:1213–1218. 2002.PubMed/NCBI
|
|
21
|
Kawasaki H, Altieri DC, Lu CD, Toyoda M,
Tenjo T and Tanigawa N: Inhibition of apoptosis by survivin
predicts shorter survival rates in colorectal cancer. Cancer Res.
58:5071–5074. 1998.PubMed/NCBI
|
|
22
|
Sarela AI, Macadam RC, Farmery SM, Markham
AF and Guillou PJ: Expression of the antiapoptosis gene, survivin,
predicts death from recurrent colorectal carcinoma. Gut.
46:645–650. 2000. View Article : Google Scholar
|
|
23
|
Sarela AI, Scott N, Ramsdale J, Markham AF
and Guillou PJ: Immunohistochemical detection of the anti-apoptosis
protein, survivin, predicts survival after curative resection of
stage II colorectal carcinomas. Ann Surg Oncol. 8:305–310. 2001.
View Article : Google Scholar
|
|
24
|
Sui L, Dong Y, Ohno M, Watanabe Y,
Sugimoto K and Tokuda M: Survivin expression and its correlation
with cell proliferation and prognosis in epithelial ovarian tumors.
Int J Oncol. 21:315–320. 2002.
|
|
25
|
Okada E, Murai Y, Matsui K, Isizawa S,
Cheng C, Masuda M and Takano Y: Survivin expression in tumor cell
nuclei is predictive of a favorable prognosis in gastric cancer
patients. Cancer Lett. 163:109–116. 2001. View Article : Google Scholar
|
|
26
|
Kennedy SM, O’Driscoll L, Purcell R,
Fitz-Simons N, McDermott EW, Hill AD, et al: Prognostic importance
of Survivin in breast cancer. Br J Cancer. 88:1077–1083. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trieb K, Lehner R, Stulnig T, Sulzbacher I
and Shroyer KR: Survivin expression in human osteosarcoma is a
marker for survival. Eur J Surg Oncol. 29:379–382. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lehner R, Lucia MS, Jarboe EA, Orlicky D,
Shroyer AL, McGregor JA and Shroyer KR: Immunohistochemical
localization of the IAP protein survivin in bladder mucosa and
transitional cell carcinoma. Appl Immunohistochem Mol Morphol.
10:134–138. 2002. View Article : Google Scholar
|
|
29
|
Tonini G, Vincenzi B, Santini D, et al:
Nuclear and cytoplasmic expression of survivin in 67 surgically
resected pancreatic cancer patients. Br J Cancer. 92:2225–2232.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vischioni B, Van der Valk P, Span SW,
Kruyt FA, Rodriguez JA and Giaccone G: Nuclear localization of
survivin is a positive prognostic factor for survival in advanced
non-small-cell lungcancer. Ann Oncol. 15:1654–1660. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ito T, Shiraki K, Sugimoto K, Yamanaka T,
Fujikawa K, Ito M, et al: Survivin promotes cell proliferation in
human hepatocellular carcinoma. Hepatology. 31:1080–1085. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grabowski P, Kühnel T, Mühr-Wilkenshoff F,
Heine B, Stein H, Höpfner M, et al: Prognostic value of nuclear
survivin expression in oesophageal squamous cell carcinoma. Br J
Cancer. 88:115–119. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tringler B, Lehner R, Shroyer AL and
Shroyer KR: Immunohistochemical localization of survivin in serous
tumors of the ovary. Appl Immunohistochem Mol Morphol. 12:40–43.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Birley HD: Human papillomaviruses,
cervical cancer and the developing world. Ann Trop Med Parasitol.
89:453–463. 1995.PubMed/NCBI
|
|
35
|
American Cancer Society. Cancer Facts and
Figures 1999. American Cancer Society; Atlanta, GA: 1999
|
|
36
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary
cause of invasive cervical cancer worldwide. J Pathol. 189:12–19.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Richart RM: Cervical intraepithelial
neoplasia. Pathol Annu. 8:301–328. 1973.PubMed/NCBI
|
|
38
|
Wright TC, Kurman RJ and Ferenczy A:
Precancerous lesions of the cervix. Blaustein’s Pathology of the
Female Genital Tract. Kurman RJ: Springer-Verlag; New York, NY: pp.
229–232. 1994
|
|
39
|
Frost M, Jarboe EA, Orlicky D, Gianani R,
Thompson LC, Enomoto T and Shroyer KR: Immunohistochemical
localization of survivin in benign cervical mucosa, cervical
dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol.
117:738–744. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie D, Zeng YX, Wang HJ, Wen JM, Tao Y,
Sham JS and Guan XY: Expression of cytoplasmic and nuclear Survivin
in primary and secondary human glioblastoma. Br J Cancer.
16:108–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
